Mineral Resources (ASX:MIN) has again dumped its dividend as bloodcurdling lithium prices sent its half-year performance deep ...

DMT's take on the knitted shoe, which works well for relaxed rides and longer distances but lacks support for hard efforts ...

ground-breaking Phase 2a DMT stroke study and we are very pleased to become an investor, as it aligns incentives for us to finish our work on-time, on-budget and with high data integrity. The ...

Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily ...

Sarah Napthali lowers her voice over lunch when our conversation veers to the names of the drugs she used: LSD, MDMA, ...

Mineral Resources (MinRes) had a record drop in trading day, down 22.1%, due to a large drop in EBITDA and slashed production ...

Piedmont Lithium Inc. ("Piedmont," the "Company," "we," "our," or "us") (Nasdaq: PLL; ASX: PLL), a leading North American ...

High out-of-pocket costs, lack of insurance coverage, or logistical difficulties in obtaining or administering DMT may also play a role, especially in countries with limited healthcare access.

Adults with relapsing MS rated the Sensoready pen, an autoinjector used to self-administer Kesimpta, for ease of use and ...

A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...

Approximately 55,700 dmt of spodumene concentrate were sold to ... Mill utilization of 90% in Q4’24 declined modestly from the record high of 91% in the prior quarter and was negatively impacted ...